Cohen & Steers (CNS) director reports 436-share RSU grant, now holds 1,738 shares

Rhea-AI Filing Summary

Cohen & Steers, Inc. reported a routine insider equity grant for one of its directors. On 01/02/2026, the director acquired 436 shares of Cohen & Steers common stock at a price of $0 per share, increasing the director’s beneficial ownership to 1,738 shares held directly.

The filing explains that these 436 shares represent common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the underlying shares are scheduled to be delivered to the director on the third anniversary of the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider THISSEN KAREN WILSON

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	436	$0.00	--

Holdings After Transaction: Common Stock — 1,738 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

THISSEN KAREN WILSON

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		436(1)	A	$0	1,738	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Remarks:

	/s/ Brian W. Heller, Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cohen & Steers (CNS) report in this Form 4?

A director of Cohen & Steers, Inc. reported acquiring 436 shares of common stock on 01/02/2026 through a restricted stock unit grant at $0 per share.

How many Cohen & Steers (CNS) shares does the director own after this transaction?

Following the reported transaction, the director beneficially owns 1,738 shares of Cohen & Steers common stock, held directly.

What are the terms of the Cohen & Steers (CNS) restricted stock units granted?

The restricted stock units were 100% vested on the grant date, and the related 436 shares of common stock will be delivered on the third anniversary of the grant date.

What was the price paid for the Cohen & Steers (CNS) shares in this Form 4 filing?

The 436 shares reported were acquired at a price of $0 per share, reflecting a grant of fully vested restricted stock units rather than an open-market purchase.

What is the role of the reporting person at Cohen & Steers (CNS)?

The reporting person is identified as a Director of Cohen & Steers, Inc. in the filing.

Does this Cohen & Steers (CNS) Form 4 involve derivative securities?

Table II for derivative securities is present but contains no entries; the report focuses on non-derivative common stock acquired through restricted stock units.